Tasly Pharmaceutical Group Co. Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 3,826.588 million compared to CNY 8,623.473 million a year ago. Operating income was CNY 1,181.132 million compared to CNY 888.546 million a year ago. Net income was CNY 1,002.171 million compared to CNY 685.965 million a year ago. Basic earnings per share from continuing operations was CNY 0.667 compared to CNY 0.4549 a year ago.